Login / Signup

Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion.

Jung-Min YiIl DohSeok-Hwan LeeSoo-Young KimYong-Hun LeeEun-Kyung LeeSoo-Han LeeByung-Moon ChoiGyu-Jeong Noh
Published in: Acta anaesthesiologica Scandinavica (2019)
The new propofol pharmacokinetic model (the Choi model) developed for underweight patient showed adequate performance for clinical use.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • case report
  • peritoneal dialysis
  • patient reported outcomes